GNRH1 and pachyonychia congenita: In a retrospective cohort study of 73,196 older patients with localized PC using the SEER database, Keating et al. first showed in 2006 that GnRH agonist use significantly increased the risk of developing coronary artery disease, myocardial infarction, and sudden cardiac death [74].